UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 93

Sortiert nach

Nutritional status and nutritional risk in patients with neuroendocrine tumors

Scandinavian journal of gastroenterology, 2018-03, Vol.53 (3), p.284-292

2018

Link zum Volltext

Verfügbarkeit prüfen

Local disease control after stereotactic body radiotherapy in patients with neuroendocrine neoplasms: a cohort study

Acta oncologica, 2023-06, Vol.62 (6), p.621-626

2023

Link zum Volltext

Verfügbarkeit prüfen

Use of biologically based complementary medicines in patients with neuroendocrine tumors

Scandinavian journal of gastroenterology, 2019-08, Vol.54 (8), p.998-1002

2019

Link zum Volltext

Verfügbarkeit prüfen

The role of Branched Chain Amino Acids in the treatment of hepatic Encephalopathy

Journal of clinical and experimental hepatology, 2018-12, Vol.8 (4), p.448-451

2018

Link zum Volltext

Verfügbarkeit prüfen

Predicting Progression, Recurrence, and Survival in Pancreatic Neuroendocrine Tumors: A Single Center Analysis of 174 Patients

Frontiers in endocrinology (Lausanne), 2022-06, Vol.13, p.925632-925632

2022

Link zum Volltext

Verfügbarkeit prüfen

Branched-chain amino acids and muscle ammonia detoxification in cirrhosis

Metabolic brain disease, 2013-06, Vol.28 (2), p.217-220

2013

Link zum Volltext

Verfügbarkeit prüfen

Effects of Peptide Receptor Radiotherapy in Patients with Advanced Paraganglioma and Pheochromocytoma: A Nation-Wide Cohort Study

Cancers, 2024-04, Vol.16 (7), p.1349

2024

Link zum Volltext

Verfügbarkeit prüfen

Lactulose, rifaximin or branched chain amino acids for hepatic encephalopathy: what is the evidence?

Metabolic brain disease, 2013-06, Vol.28 (2), p.221-225

2013

Link zum Volltext

Verfügbarkeit prüfen

Protein tolerance to standard and high protein meals in patients with liver cirrhosis

World journal of hepatology, 2017-05, Vol.9 (14), p.667-676

2017

Link zum Volltext

Verfügbarkeit prüfen

Diabetes does not increase infection risk or mortality following an infection in patients with cirrhosis and ascites

JHEP reports, 2019-10, Vol.1 (4), p.265-269

2019

Link zum Volltext

Verfügbarkeit prüfen

Brain edema: a valid endpoint for measuring hepatic encephalopathy?

Metabolic brain disease, 2016-12, Vol.31 (6), p.1249-1258

2016

Link zum Volltext

Verfügbarkeit prüfen

First-generation somatostatin ligand receptor treatment in a pregnant patient with a neuroendocrine tumor with liver metastases

Endocrinology, diabetes & metabolism case reports, 2021-10, Vol.2021 (1), p.1-5

2021

Link zum Volltext

Verfügbarkeit prüfen

Proton pump inhibitors as a risk factor for hepatic encephalopathy and spontaneous bacterial peritonitis in patients with cirrhosis with ascites

Hepatology (Baltimore, Md.), 2016-10, Vol.64 (4), p.1265-1272

2016

Link zum Volltext

Verfügbarkeit prüfen

Branched-chain amino acids for people with hepatic encephalopathy

Cochrane database of systematic reviews, 2017-05, Vol.5 (5), p.CD001939-CD001939

2017

Link zum Volltext

Verfügbarkeit prüfen

Physical exercise for people with cirrhosis

Cochrane database of systematic reviews, 2018-12, Vol.12 (12), p.CD012678-CD012678

2018

Link zum Volltext

Verfügbarkeit prüfen

Resistance Training Increases Muscle Strength and Muscle Size in Patients With Liver Cirrhosis

Clinical gastroenterology and hepatology, 2020-05, Vol.18 (5), p.1179-1187.e6

2020

Link zum Volltext

Verfügbarkeit prüfen

Fatigue and quality of life in patients with neuroendocrine neoplasia

Scandinavian journal of gastroenterology, 2023-01, Vol.58 (1), p.45-53

2023

Link zum Volltext

Verfügbarkeit prüfen

Ammonia: This is not the end but rather the end of the beginning

Journal of hepatology, 2018-06, Vol.68 (6), p.1110-1113

2018

Link zum Volltext

Verfügbarkeit prüfen

Effect of proton pump inhibitors on the risk and prognosis of infections in patients with cirrhosis and ascites

Liver international, 2019-03, Vol.39 (3), p.514-521

2019

Link zum Volltext

Verfügbarkeit prüfen

Low cerebral energy metabolism in hepatic encephalopathy reflects low neuronal energy demand. Role of ammonia-induced increased GABAergic tone

Analytical biochemistry, 2022-10, Vol.654, p.114766-114766, Article 114766

2022

Link zum Volltext

Verfügbarkeit prüfen

Branched-chain amino acids for people with hepatic encephalopathy

Cochrane database of systematic reviews, 2015-02 (2), p.CD001939-CD001939

2015

Link zum Volltext

Verfügbarkeit prüfen

Reduced 3‐year risk of hospital admission and mortality after 12‐week resistance training of cirrhosis patients: A follow‐up of a randomized clinical trial

Journal of gastroenterology and hepatology, 2023-08, Vol.38 (8), p.1365-1371

2023

Link zum Volltext

Verfügbarkeit prüfen

Reply

Hepatology (Baltimore, Md.), 2017-07, Vol.66 (1), p.295-296

2017

Link zum Volltext

Verfügbarkeit prüfen

Reply

Hepatology (Baltimore, Md.), 2017-07, Vol.66 (1), p.295-296

2017

Link zum Volltext

Verfügbarkeit prüfen

Reply

Hepatology (Baltimore, Md.), 2017-07, Vol.66 (1), p.295

2017

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 93

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(90)
Mit Volltextzugriff
(84)

Publikationsform

Artikel
(93)

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Nutritional status and nutritional risk in patients with neuroendocrine tumors

Local disease control after stereotactic body radiotherapy in patients with neuroendocrine neoplasms: a cohort study

Use of biologically based complementary medicines in patients with neuroendocrine tumors

The role of Branched Chain Amino Acids in the treatment of hepatic Encephalopathy

Predicting Progression, Recurrence, and Survival in Pancreatic Neuroendocrine Tumors: A Single Center Analysis of 174 Patients

Branched-chain amino acids and muscle ammonia detoxification in cirrhosis

Effects of Peptide Receptor Radiotherapy in Patients with Advanced Paraganglioma and Pheochromocytoma: A Nation-Wide Cohort Study

Lactulose, rifaximin or branched chain amino acids for hepatic encephalopathy: what is the evidence?

Protein tolerance to standard and high protein meals in patients with liver cirrhosis

Diabetes does not increase infection risk or mortality following an infection in patients with cirrhosis and ascites

Brain edema: a valid endpoint for measuring hepatic encephalopathy?

First-generation somatostatin ligand receptor treatment in a pregnant patient with a neuroendocrine tumor with liver metastases

Proton pump inhibitors as a risk factor for hepatic encephalopathy and spontaneous bacterial peritonitis in patients with cirrhosis with ascites

Branched-chain amino acids for people with hepatic encephalopathy

Physical exercise for people with cirrhosis

Resistance Training Increases Muscle Strength and Muscle Size in Patients With Liver Cirrhosis

Fatigue and quality of life in patients with neuroendocrine neoplasia

Ammonia: This is not the end but rather the end of the beginning

Effect of proton pump inhibitors on the risk and prognosis of infections in patients with cirrhosis and ascites

Low cerebral energy metabolism in hepatic encephalopathy reflects low neuronal energy demand. Role of ammonia-induced increased GABAergic tone

Branched-chain amino acids for people with hepatic encephalopathy

Reduced 3‐year risk of hospital admission and mortality after 12‐week resistance training of cirrhosis patients: A follow‐up of a randomized clinical trial

Reply

Reply

Reply

Suchergebnisse filtern